Navigation Links
Valeant Pharmaceuticals Increases Proposed Price for Acquisition of ISTA Pharmaceuticals Inc. to $7.50 Per Share in Cash
Date:1/17/2012

MISSISSAUGA, Ontario, Canada, Jan. 17, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has increased from $6.50 to $7.50 per share in cash the proposed price of its previously  announced offer to acquire ISTA Pharmaceuticals Inc. (Nasdaq: ISTA).  Valeant also communicated to ISTA that Valeant believed that it could achieve a price of up to $8.50 per share, assuming that ISTA provides it selected confirmatory due diligence related to the company that is consistent with what Valeant expects to see.  Valeant reaffirmed that its proposal would only remain open until January 31, 2012.  A copy of a letter from Valeant to the Board of Directors of ISTA is attached to this press release. 

Since December 16, 2011, the date on which Valeant publicly announced its proposal to acquire ISTA at $6.50 per share in cash, ISTA's stock has traded in a range significantly higher than in the months prior to that announcement.  The proposed price of $7.50 per share represents a premium of approximately 94% over ISTA's 60-day volume weighted trading average of $3.87 on December 15, 2011, the last trading day before Valeant's public announcement of its offer.  An $8.50 per share price would constitute a premium of approximately 120%.

After repeated attempts to enter into acquisition negotiations, in December 2011 Valeant announced that it had made a proposal to the Board of Directors of ISTA to acquire the company for $6.50 per share in cash.  At that time, Valeant made clear that its proposal would remain in effect only until January 31, 2012.  Valeant again reiterated its January 31 deadline.

Valeant expressed its disappointment that the Board of Directors and management of ISTA have not been willing to meaningfully engage with Valeant on a timely basis to obtain the b
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Fleming Pharmaceuticals Sells Ocean, Nephrocaps, Other Branded Products to Valeant
2. Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
3. Valeant Pharmaceuticals Completes Acquisition of iNova
4. Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance
5. Valeant Pharmaceuticals Completes Acquisition of Dermik
6. Valeant Announces Successful Results From Phase III Onychomycosis Trials
7. Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
8. Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik
9. Valeant Pharmaceuticals to Syndicate Incremental Term Loans
10. Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
11. Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... and VANCOUVER , July ... ) announced today that it will report its second ... Company management will host a conference call and live ... overview of financial results, clinical development programs and a ... webcast, log on to the Investor Relations page of ...
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced the ... of Warburg Pincus LLC, to the Amgen Board of Directors. ... Hassan and the deep, global experience he brings in ... A. Bradway , chairman and chief executive officer of Amgen. "Fred,s ... Amgen well." Mr. Hassan has been Partner and ...
(Date:7/30/2015)... N.J. , July 30, 2015 Eisai ... in the United States , European ... FDA, EMA and MHLW, respectively) for eribulin, for the ... who have received prior chemotherapy for advanced or metastatic ... on data from a pivotal global Phase 3 clinical ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... YORK, Jan. 13, 2011 Reportlinker.com announces that ... its catalogue: Merck & Co., ... IntroductionThis analysis examines the ... in the prescription pharmaceutical sector. The profile encompasses ...
... Codexis, Inc. (Nasdaq: CDXS) today announced the company will host ... at 4:30 p.m. Eastern Time to discuss its fourth quarter ... call and webcast will follow the release of fourth quarter ... call will be available approximately one hour after the call ...
Cached Medicine Technology:Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on ... and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the ... allows users to clarify, edit and delete any message including ones already sent. , ...
(Date:7/31/2015)... Ind. (PRWEB) , ... August 01, 2015 , ... The ... the Global Advisory Panel on the Future of Nursing (GAPFON) 20-21 July 2015 in ... invited to participate in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... run by GoodThreads. The store can be accessed by visiting http://www.curemeso.org/store . ... which are customizable. The best part: whenever a product is purchased, the Meso ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin ... re-branded their social media profiles to better connect with the public. The agency ... find information, share insights and opinions. The Rally Insurance Group, Inc.’s pledge to ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an article ... see if they could reach a consensus on the steps that need to be ... the group reached 90 percent consensus on a series of steps that each surgeon ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... Growth Initiatives, ROCHESTER, N.Y., Sept. 17 ... completed a private placement of,$4,350,000 of Series B ... institutional and other accredited investors. VirtualScopics,currently intends to ... expand its,sales and marketing efforts, software and technology ...
... Sept. 17 CryoCor, Inc. (Nasdaq:,CRYO), a medical device ... that Edward F. Brennan, President and Chief,Executive Officer, and ... at the Maxim Group First Annual Growth Conference in,New ... a.m. ET at The Grand,Hyatt Hotel. A live ...
... St. Margaret,s Daughters, Home, NEW ORLEANS, Sept. 17 ... New Orleans will be reunited in a,temporary facility this ... Hurricane Katrina. The 116-bed eldercare facility was destroyed ... Ninth Ward. While everyone at St.,Margaret,s was evacuated safely ...
... John Brooke, General Manager of,Billian,s HealthDATA, leading provider ... ,07 Global Gathering, Salesforce.com,s 5th,Annual User and Developer ... is the ultimate gathering of the salesforce.com community,bringing ... and AppExchance,users spanning industries, roles and locales. Mr. ...
... time scientists have been able to film, in real ... DNA strand from an attacking virus. Researchers from the ... Force Microscope in Japan to produce amazing footage of ... trying to infect a bacterial host. , The ...
... may only be modestly accurate, according to researchers from the ... Carolina. In a study that appears in the October issue ... usefulness of a scale that asks patients in primary care ... 10 (worst pain). , Universal pain screening is ...
Cached Medicine News:Health News:VirtualScopics Announces $4.35 Million Private Placement 2Health News:VirtualScopics Announces $4.35 Million Private Placement 3Health News:CryoCor to Present at Maxim Group First Annual Growth Conference in New York 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 3Health News:Billian's HealthDATA GM Speaking on Dreamforce 07 Panel 2Health News:Scientists reveal DNA-enzyme interaction with first ever real time footage 2Health News:Rating your pain from 0 to 10 might not help your doctor 2
Simply stated, no bone cement can match the history of Simplex™. Simplex™ is the only cement with 40 years of proven clinical performance - trusted by tens of thousands of surgeons with o...
DePuy 2 Bone Cement is a unique fast-set digital cement that is the excellent choice for small joint procedures such as the patella, glenoid or other extremity joints....
... John Charnley and CMW, Inc. began ... bone cements exclusively for orthopaedic applications. ... years of performance and excellence in ... one of the first proven bone ...
... Paradigm's Dicon Ocular Blood Flow Analyzer is ... increase your early diagnosis of low and ... (BFA) provides a fast, clinically proven measurement ... BFA assists in the management of glaucoma, ...
Medicine Products: